APUS vs GOOGL: Which Stock is Better?
Side-by-side comparison of Apimeds Pharmaceuticals Us Inc and Alphabet Inc in 2026
APUS
Apimeds Pharmaceuticals Us Inc
$1.88
GOOGL
Alphabet Inc
$341.06
Key Metrics Comparison
| Metric | APUS | GOOGL | Winner |
|---|---|---|---|
| Market Cap | $23.64M | N/A | APUS |
| P/E Ratio | N/A | 31.64 | GOOGL |
| EPS (TTM) | $N/A | $10.80 | GOOGL |
| Revenue Growth | 0.0% | 0.2% | GOOGL |
| Gross Margin | 0.0% | 59.7% | GOOGL |
Analyze APUS
Full quant analysis
Analyze GOOGL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APUS or GOOGL a better investment?
Comparing APUS and GOOGL: Apimeds Pharmaceuticals Us Inc has a market cap of $23.64M while Alphabet Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APUS and GOOGL?
APUS (Apimeds Pharmaceuticals Us Inc) and GOOGL (Alphabet Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APUS or GOOGL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APUS or GOOGL?
GOOGL has higher revenue growth at 0.2% vs 0.0% for APUS.
Which company is more profitable: APUS or GOOGL?
Alphabet Inc (GOOGL) has higher gross margins at 59.7% compared to 0.0% for APUS.
Which is the larger company: APUS or GOOGL?
Apimeds Pharmaceuticals Us Inc (APUS) is larger with a market cap of $23.64M compared to N/A for GOOGL.
Should I buy APUS or GOOGL in 2026?
Both APUS and GOOGL have investment merit. APUS trades at $1.88 while GOOGL trades at $341.06. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APUS and GOOGL stock?
Key differences: Market Cap ($23.64M vs N/A), P/E Ratio (N/A vs 31.6x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 59.7%).